Plain-English translation of NCT05037279 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Bladder Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new form of bladder cancer treatment called VERITY-BCG to see if it works as well as the current standard treatment (OncoTICE) at preventing cancer from coming back. Both treatments are delivered directly into the bladder through a catheter. The study will follow patients for two years to compare how well each treatment prevents tumor recurrence.
The current standard bladder cancer treatment has been used for decades, but doctors want to find out if this medication might work just as well or better, with potentially fewer side effects or complications.
You likely qualify if…
You likely don't qualify if…
Participants will receive bladder treatments (instillations) on a regular schedule over several weeks. You'll be randomly assigned to receive either the new treatment or the standard treatment, and neither you nor your doctors will know which one you're getting. Over the next two years, you'll have regular follow-up visits including cystoscopy (a camera test to look inside the bladder) to check for any cancer recurrence, along with blood work and imaging studies as needed.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Canada